We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · October 03, 2019

No Benefit of High-Dose Chemotherapy in Ewing Sarcoma With Pulmonary Metastases

Journal of Clinical Oncology


Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Clinical Oncology
High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008
J. Clin. Oncol 2019 Sep 25;[EPub Ahead of Print], U Dirksen, B Brennan, MC Le Deley, N Cozic, H van den Berg, V Bhadri, B Brichard, L Claude, A Craft, S Amler, N Gaspar, H Gelderblom, R Goldsby, R Gorlick, HE Grier, JM Guinbretiere, P Hauser, L Hjorth, K Janeway, H Juergens, I Judson, M Krailo, J Kruseova, T Kuehne, R Ladenstein, C Lervat, SL Lessnick, I Lewis, C Linassier, P Marec-Berard, N Marina, B Morland, H Pacquement, M Paulussen, RL Randall, A Ranft, G Le Teuff, K Wheatley, J Whelan, R Womer, O Oberlin, DS Hawkins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading